Q2 2026 13F filing
Updated 27 days ago88 disclosed positions worth $524.4M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R RVMDW REVOLUTION MEDICINES INC | $105.4M | 562.6K | 20.09% | — |
| 2 | S STT-PG SPDR S&P BIOTECH ETF | $31.1M | 196.5K | 5.93% | — |
| 3 | C CMPS COMPASS PATHWAYS PLC | $28.5M | 2.01M | 5.43% | — |
| 4 | S STXS STEREOTAXIS INC | $23.5M | 13.68M | 4.49% | — |
| 5 | N NKTR NEKTAR THERAPEUTICS | $22.2M | 318.4K | 4.24% | — |
| 6 | D DNLI DENALI THERAPEUTICS INC | $19M | 739.0K | 3.62% | — |
| 7 | I IDYA IDEAYA BIOSCIENCES INC | $18.5M | 497.2K | 3.53% | — |
| 8 | A ATRC ATRICURE INC | $16.7M | 597.4K | 3.19% | — |
| 9 | X XENE XENON PHARMACEUTICALS INC | $15.1M | 250.8K | 2.89% | — |
| 10 | C CYTK CYTOKINETICS INC | $14.7M | 172.0K | 2.79% | — |
| 11 | R RCUS ARCUS BIOSCIENCES INC | $13.6M | 441.8K | 2.60% | — |
| 12 | A ASND ASCENDIS PHARMA A/S | $12.9M | 48.5K | 2.47% | — |
| 13 | N NBIX NEUROCRINE BIOSCIENCES INC | $9.7M | 57.8K | 1.86% | — |
| 14 | A AXGN AXOGEN INC | $9.7M | 209.0K | 1.84% | — |
| 15 | P PODD INSULET CORP | $9.4M | 61.9K | 1.80% | — |
| 16 | E EWTX EDGEWISE THERAPEUTICS INC | $9.2M | 226.8K | 1.76% | — |
| 17 | B BCAX BICARA THERAPEUTICS INC | $8.5M | 285.0K | 1.61% | — |
| 18 | E ETHA ISHARES NASDAQ BIOTECH INDX | $8.1M | 42.6K | 1.54% | — |
| 19 | S SNDX SYNDAX PHARMACEUTICALS INC | $7.3M | 335.3K | 1.40% | — |
| 20 | M MPLT MAPLIGHT THERAPEUTICS INC | $6.1M | 171.0K | 1.17% | — |
| 21 | L LRMR LARIMAR THERAPEUTICS INC | $6.1M | 2.01M | 1.17% | — |
| 22 | C CRNC CENTURY THERAPEUTICS INC | $5.9M | 2.40M | 1.12% | — |
| 23 | D DXCM DEXCOM INC | $5.8M | 86.3K | 1.11% | — |
| 24 | I IMVT IMMUNOVANT INC | $5.8M | 149.5K | 1.10% | — |
| 25 | I INGN INOGEN INC | $5.5M | 845.2K | 1.04% | — |
| 26 | T TNDM TANDEM DIABETES CARE INC | $5.4M | 355.2K | 1.02% | — |
| 27 | A ALKS ALKERMES PLC | $5.3M | 101.3K | 1.01% | — |
| 28 | S STOK STOKE THERAPEUTICS INC | $4.3M | 130.9K | 0.82% | — |
| 29 | A ALLO ALLOGENE THERAPEUTICS INC | $4.2M | 2.00M | 0.79% | — |
| 30 | B BCRX BIOCRYST PHARMACEUTICALS INC | $4M | 400.2K | 0.76% | — |
| 31 | G GLPGF LAKEFRONT BIOTHERAPEUTICS NV | $3.9M | 130.2K | 0.74% | — |
| 32 | K KIDS ORTHOPEDIATRICS CORP | $3.6M | 189.1K | 0.69% | — |
| 33 | H HELP CYBIN INC | $3.4M | 514.1K | 0.65% | — |
| 34 | R RAPP RAPPORT THERAPEUTICS INC | $3.1M | 75.0K | 0.60% | — |
| 35 | K KYMR KYMERA THERAPEUTICS INC | $3.1M | 27.0K | 0.59% | — |
| 36 | P PRQR PROQR THERAPEUTICS NV | $2.8M | 1.53M | 0.54% | — |
| 37 | N NGNE NEUROGENE INC | $2.8M | 89.0K | 0.53% | — |
| 38 | A ANL ADLAI NORTYE LTD | $2.8M | 239.6K | 0.53% | — |
| 39 | P PRCT PROCEPT BIOROBOTICS CORP | $2.7M | 120.0K | 0.52% | — |
| 40 | A AQST AQUESTIVE THERAPEUTICS INC | $2.7M | 645.9K | 0.51% | — |
| 41 | C CLDX CELLDEX THERAPEUTICS INC | $2.5M | 68.5K | 0.49% | — |
| 42 | G GPCR STRUCTURE THERAPEUTICS INC | $2.5M | 46.5K | 0.48% | — |
| 43 | A ALGN ALIGN TECHNOLOGY INC | $2.4M | 14.0K | 0.45% | — |
| 44 | V VIK VIKING THERAPEUTICS INC | $2.3M | 59.5K | 0.44% | — |
| 45 | N NGEN NERVGEN PHARMA CORP | $2.2M | 1.05M | 0.41% | — |
| 46 | B BHVN BIOHAVEN LTD | $2M | 137.6K | 0.39% | — |
| 47 | M MAZE MAZE THERAPEUTICS INC | $1.9M | 65.0K | 0.37% | — |
| 48 | A ALEC ALECTOR INC | $1.8M | 908.4K | 0.35% | — |
| 49 | ? N/A LEXEO THERAPEUTICS INC | $1.8M | 377.1K | 0.33% | — |
| 50 | P PROF PROFOUND MEDICAL CORP | $1.7M | 260.4K | 0.33% | — |